New combo therapy aims to soothe pain and stiffness after head and neck cancer surgery
NCT ID NCT07334938
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether far infrared therapy (gentle heat) and TENS (mild electrical pulses) can reduce pain and improve neck movement in people recovering from head and neck cancer surgery. 90 patients will be split into three groups: one getting usual care, one getting TENS, and one getting both treatments. Each treatment is applied twice daily for five days, with results measured on day one and day five.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- Far infrared therapy and transcutaneous electrical nerve stimulation (TENS)
- What this could lead to
- If it works, this could offer a simple, drug-free way to ease pain and improve neck mobility after head and neck cancer surgery.
- What could go wrong
- This is a small, early-stage trial with only 90 participants. The treatment is short (5 days), so any benefits may be temporary. Results may not apply to all patients.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
90 people
The number who actually took part.
- Started
-
May 2024
- Expected to finish
-
Mar 2026
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
30 to 85 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria 1. Patients aged 30 to 85 years with a confirmed diagnosis of head and neck cancer. 2. Patients scheduled to undergo surgical resection. 3. Patients who are conscious, able to communicate verbally or in writing, and willing to complete questionnaires and comply with all study procedures. Exclusion Criteria: 1. Presence of open wounds or skin lesions at the sites where transcutaneous acupoint electrical stimulation electrodes would be applied. 2. Contraindications to transcutaneous acupoint electrical stimulation, including a history of epilepsy, brain tumors, arteriovenous malformations, or implanted cardiac pacemakers or defibrillators, to avoid potential adverse effects of electrical stimulation.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Head and neck cancer (H&N) are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation
Hualien City, Hualien County, 97002, Taiwan
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could daily swallowing exercises ease a harsh side effect of cancer treatment?
- Immune cells may hold the key to faster recovery after facial surgery
- Brain games may rev up thinking and driving after cancer treatment
- New imaging tracer could spot hidden cancers and fibrosis in one scan
- Heat and pulses: new combo therapy aims to soften cancer Treatment's harsh toll
- Bacteria in the mouth and gut may predict who responds to cancer immunotherapy